Drug intelligence / Profile preview

Ganmao Qing Pian

Development stage: Unknown
Lead developer: Guangdong Xinfeng Pharmaceutical Industry
Modality: Small Molecules
Administration: Oral

Overview

Ganmao Qing Pian (感冒清片) is an approved over-the-counter (OTC) traditional Chinese medicine (TCM) oral tablet developed and marketed by Guangdong Xinfeng Pharmaceutical. It is indicated for the symptomatic relief of the common cold, upper respiratory tract infections, and sore throat. As a multi-component herbal formulation, it is designed according to traditional Chinese medicine principles to clear heat and resolve exterior symptoms. The product works through the synergistic effects of its constituent herbal ingredients rather than targeting a single specified molecular pathway.

Brand names: 感冒清片Ganmao Qing Pian

Beyond the preview

Go deeper on Ganmao Qing Pian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganmao Qing Pian.

Explore the full profile